Genomic Health

GHDX NASDAQ
73.26
-0.26
-0.35%
After Hours: 73.26 0 0.00% 16:09 08/23 EDT
Open
73.40
Prev Close
73.52
High
74.11
Low
72.81
Volume
317.80K
Avg Vol (3M)
705.21K
52 Week High
92.18
52 Week Low
50.77
% Turnover
0.85%
Market Cap
2.73B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Genomic Health GHDX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Genomic Health, Inc. is a healthcare company that provides genomic-based diagnostic tests to personalize cancer treatment. The Company develops and commercializes genomic-based clinical laboratory services. The Company's Oncotype IQ Genomic Intelligence Platform is consisted of its flagship line of Oncotype DX gene expression tests, as well as its Oncotype SEQ Liquid Select test. Its research and development activities are focused on developing a pipeline of tests to optimize the treatment of various cancers including breast, colon, prostate and other cancers. It offers its Oncotype DX tests as a clinical laboratory service, where it analyzes the expression levels of genes in tumor tissue samples and provides physicians with a quantitative gene expression profile expressed as a single quantitative score, which it calls a Recurrence Score for invasive breast cancer and colon cancer, a DCIS Score for ductal carcinoma in situ (DCIS), and a Genomic Prostate Score, for prostate cancer.
MORE >

Recently

Name
Price
%Change